Quick Takeaways
- This page summarizes Jonathan D. Root's Form 4 filing for Edgewise Therapeutics, Inc. (EWTX).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 14 Jun 2023, 19:29.
Jonathan D. Root - 12 Jun 2023 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)
- Role
- Director
- Signature
- /s/ John R. Moore Attorney-in-Fact for Jonathan Root M.D.
- Issuer symbol
- EWTX
- Transactions as of
- 12 Jun 2023
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 14 Jun 2023, 19:29:32 UTC
- Previous filing
- 30 May 2023
- Next filing
- 26 Apr 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Jonathan D. Root filed Form 4 for Edgewise Therapeutics, Inc. (EWTX) on 14 Jun 2023."
What Changed
- Previous filing in this sequence was filed on 30 May 2023.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
EWTX
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +22,123
- Change %
- Price
- $0.000000
- Shares after
- 22,123
- Date
- 12 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,123
- Exercise price
- $9.55
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | 100% of the Stock Options granted on June 12, 2023 will become vested on the earlier of (i) June 12, 2024 or (ii) the business day prior to the date of the 2024 annual meeting of stockholders. |